Avoiding malnutrition in the era of GLP-1 medications: emerging evidence and opportunities for integrated nutrition care
{{output}}
Glucagon-like peptide-1 (GLP-1)-based therapies have transformed obesity treatment, resulting in significant weight loss and broad metabolic improvements. However, their rapid adoption has outpaced the development of adequate nutritional support systems, leavi... ...
